Provided by Tiger Trade Technology Pte. Ltd.

Clene Inc

4.23
+0.12002.92%
Post-market: 4.230.00000.00%18:54 EST
Volume:49.47K
Turnover:208.82K
Market Cap:49.82M
PE:-1.29
High:4.41
Open:4.26
Low:4.10
Close:4.11
52wk High:13.50
52wk Low:2.28
Shares:11.78M
Float Shares:8.84M
Volume Ratio:0.71
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2913
EPS(LYR):-5.6657
ROE:-1738.36%
ROA:-56.24%
PB:-4.03
PE(LYR):-0.75

Loading ...

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Feb 03

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Jan 29

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Jan 22

JonesTrading Sticks to Their Buy Rating for Clene (CLNN)

TIPRANKS
·
Jan 17

10% Owner Chidozie Ugwumba Reports Sale of Clene Inc. Common Shares

Reuters
·
Jan 17

Clene Inc. to Present Corporate Update at Emerging Growth Conference

Reuters
·
Jan 16

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Jan 13

Clene Inc. Reports Biomarker Data Linking CNM-Au8 to Reduced ALS Mortality Risk

Reuters
·
Jan 12

Clene Announces Additional Cnm-AU8 Biomarker Data Supporting Potential Nda Filing for Upcoming in-Person FDA Meeting

THOMSON REUTERS
·
Jan 12

BRIEF-Clene Announces Registered Direct Offering Of Over $28 Million

Reuters
·
Jan 09

10% Owner Chidozie Ugwumba Reports Sale of Clene Inc. Common Shares

Reuters
·
Jan 08

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Dec 31, 2025

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Dec 24, 2025

Have Insiders Sold Clene Shares Recently?

Simply Wall St.
·
Dec 21, 2025

10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares

Reuters
·
Dec 19, 2025

Clene Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Dec 10, 2025

Clene Inc. to Present Corporate Update at Emerging Growth Conference

Reuters
·
Dec 09, 2025

Clene Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Dec 04, 2025

BRIEF-Clene Announces Statistically Significant ALS Biomarker Results

Reuters
·
Dec 03, 2025

Clene Reports Statistically Significant ALS Biomarker Results for CNM-Au8 Supporting Accelerated FDA Approval Pathway

Reuters
·
Dec 03, 2025